University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Curt A. Ries, MD

Curt A. Ries, MD

Professor, Department of Medicine (Hematology/Oncology), UCSF

Education

Johns Hopkins University, 1957-1960, Biological Sciences
University of Rochester School of Medicine, M.D., 1960-1964, Medicine


Professional Experience

  • 1964-1965
    Intern in Medicine, Strong Memorial Hospital, Rochester, NY
  • 1965-1966
    Assistant Resident in Medicine, Strong Memorial Hospital, Rochester, NY
  • 1968-1969
    Resident in Medicine (II), University of California Hospitals, San Francisco, CA
  • 1969-1970
    Chief Resident in Medicine, University of California Hospitals (San Francisco General Hospital), San Francisco, CA
  • 1970-1972
    Fellow in Hematology, University of California, San Francisco, CA
  • 1972-1976
    Assistant Clinical Professor of Medicine, Laboratory Medicine, and Radiology (Nuclear Medicine), University of California, San Francisco, CA
  • 1972-1974
    Chief, Hematology Clinic, University of California Medical Center, San Francisco, CA
  • 1974-1980
    Director, Hematology & Oncology Clinics, University of California Medical Center, San Francisco, CA
  • 1976-1983
    Associate Clinical Professor of Medicine and Laboratory Medicine, University of California, San Francisco, CA
  • 1989-1991
    Director, Adult Bone Marrow Transplant Program, University of California Medical Center, San Francisco, CA
  • 1975-2002
    Director, Outpatient Transfusion Service, University of California Medical Center, San Francisco, CA
  • 1980-2002
    Director, Hematology/Oncology Faculty Practice, University of California Medical Center, San Francisco, CA
  • 1983-2003
    Clinical Professor of Medicine, University of California, San Francisco, CA
  • 2003-present
    Clinical Professor of Medicine Emeritus, University of California, San Francisco, CA

Selected Publications

  1. Damon L, Rugo H, Tolaney S, Navarro W, Martin T, Ries C, Case D, Ault K, Linker C. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim. Biol Blood Marrow Transplant. 2006 Mar; 12(3):316-24.
    View on PubMed
  2. Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Cancer Chemother Pharmacol. 2004 Jun; 53(6):468-74.
    View on PubMed
  3. Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C. High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia. Biol Blood Marrow Transplant. 2003 Oct; 9(10):643-8.
    View on PubMed
  4. Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol. 2002 May 15; 20(10):2464-71.
    View on PubMed
  5. Ries C, Loher F, Zang C, Ismair MG, Petrides PE. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res. 1999 May; 5(5):1115-24.
    View on PubMed
  6. Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC, Beer M, Ahmed T. A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Leukemia. 1997 Apr; 11(4):485-9.
    View on PubMed
  7. Damon L, Adams M, Stricker RB, Ries C. Intracranial bleeding during treatment with hydroxyethyl starch. N Engl J Med. 1987 Oct 08; 317(15):964-5.
    View on PubMed
  8. Mordenti J, Ries C, Brooks GF, Unadkat N, Tseng A. Vancomycin-induced neutropenia complicating bone marrow recovery in a patient with leukemia. Case report and review of the literature. Am J Med. 1986 Feb; 80(2):333-5.
    View on PubMed

Go to UCSF Profiles, powered by CTSI